DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study

To investigate the prognostic value of DHCR24 for patients with bladder cancer (BC). We used public bladder cancer microarray studies to evaluate the expression of DHCR24 between normal bladder tissues and BC cells, to investigate the relationship between the expression of DHCR24 and the clinical fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiao-Ping, Yin, Xiao-Hong, Meng, Xiang-Yu, Yan, Xin-Hui, Cao, Yue, Zeng, Xian-Tao, Wang, Xing-Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181456/
https://www.ncbi.nlm.nih.gov/pubmed/30278482
http://dx.doi.org/10.1097/MD.0000000000011830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181456/
https://www.ncbi.nlm.nih.gov/pubmed/30278482
http://dx.doi.org/10.1097/MD.0000000000011830

Ejemplares similares